Methionine-enkephalin stimulates interleukin-6 mRNA expression: Human plasma levels in coronary artery bypass grafting

International Journal of Cardiology

Volumn 64, Issue SUPPL. 1, 1998, Pages

  Zhong, Fei ^a   Li, Xiao Yu ^a   Yang, Sheng Li ^b   Stefano, George B ^c   Fimiani, Caterina ^d   Bilfinger, Thomas V ^e  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gene expression; Human plasma; Interleukin 6; Messenger RNA; Methionine enkephalin

Indexed keywords

COMPLEMENTARY DNA; DACTINOMYCIN; GUANIDINE DERIVATIVE; INTERLEUKIN 6; MESSENGER RNA; METENKEPHALIN; OPIATE PEPTIDE; SARCOSINE; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IN SITU HYBRIDIZATION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

ANIMALS; CORONARY ARTERY BYPASS; ENKEPHALIN, METHIONINE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, MESSENGER; UP-REGULATION;

EID: 0032580185     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00036-9     Document Type: Article

References (23)

1. Stefano GB, Scharrer B, Smith EM et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996;16:109-44.
2. Stefano GB, Melchiorri P, Negri L, Hughes TK, Scharrer B. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA 1992;89:9316-20.
3. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz E. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 1991;78:1834-41.
4. Van Snick J. Interleukin-6, an overview. Ann Rev Immunol 1990;8:253-78.
5. Tonnesen E, Christensen VB, Toft P. The role of cytokines in cardiac surgery. Int J Cardiol 1996;53(Suppl):S1-S10.
6. Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric thiocyanate-phenol-chloroform extraction. J Immunol Methods 1986;93:157-65.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
8. Stefano GB, Cadet P, Scharrer B. Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor. Proc Natl Acad Sci USA 1989;86:6307-11.
9. Yang SX, Li XY. Enhancement of interleukin-1 production in mouse peritoneal macrophages methionine-enkephtilin. Acta Pharmacol Sin 1989;10:266-70.
10. Brown SL, Van Epps DE. Opioid peptides modulate production of interferon gamma by human mononuclear cells. Cell Immunol 1986;103:19-26.
11. Joseph J, Grun JL, Lublin FD, Knober RL. Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4,JHM). J Neuroimmunol 1993;42:47-52.
12. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-k transcription factor. Mol Cell Biol 1990;10:2327-34.
13. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H. Macrophage differentiation-specific expression of NF-IL-6: a transcription factor for interleukin-6. Blood 1992;79:460-6.
14. Dauber IM, Parsons PE, Welsh CH. Peripheral bypass induced pulmonary and coronary vascular injury: association with increased levels of tumor necrosis factor. Circulation 1993;88:726-35.
15. Kukielka GL, Smith CW, Manning AM. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation 1995;92:1866-75.
16. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anesth 1993;40:1016-21.
17. Hennein HA, Ebba H, Rodriguez JL. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:626-35.
18. Lindal S, Gunnes S, Lund I, Straume BK, Jorgensen L, Sorlie D. Myocardial and microvascular injury following surgery and its attenuation by mode of reperfusion. Eur J Cardiothorac Surg 1995;9:83-9.
19. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-41.
20. Wan S, DeSemet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:806-11.
21. Bilfinger TV, Fricchione GL, Stefano GB. Neuroimmune implications of cardiopulmonary bypass. Adv Neuroimmunol 1993;3:277-88.
22. Tabardel Y, Duchateau J, Schmartz D. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996;119:76-80.
23. Steinberg BM, Grossi EA, Schwartz DS. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995;60:525-9.